Literature DB >> 4177796

Observations on the levels of gamma G, gamma A, gamma M globulins, anti-A and anti-B agglutinins, and antibodies to Escherichia coli in Down's anomaly.

M Adinolfi, B Gardner, W Martin.   

Abstract

The levels of gammaG, gammaA, and gammaM globulins were estimated in a group of patients with Down's anomaly and in groups of mentally retarded children and normal children, matched for age and sex, using an immunological method. Higher levels of gammaG globulin were observed in patients with Down's syndrome, in association with a small but significant lower concentration of gammaM globulin. The titres of anti-A and anti-B agglutinins and antibodies to Escherichia coli, estimated before and after treatment of serum with 2-mercaptoethanol, were found to be within normal levels. These data seem to suggest that patients with Down's syndrome do not produce ;faulty' immunoglobulins as has been previously postulated. It is suggested that the abnormal levels of immunoglobulins found in Down's anomaly are not peculiar to patients with Down's syndrome but occur in other disorders in which the reticuloendothelial system or the lymphocytes are involved.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4177796      PMCID: PMC473627          DOI: 10.1136/jcp.20.6.860

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  BIOCHEMICAL STUDIES IN MONGOLISM. III. STRUCTURES OF GAMMA-GLOBULINS FROM MONGOLOID BLOOD.

Authors:  E R FLUCK; G H PRITHAM
Journal:  Am J Ment Defic       Date:  1964-07

2.  INFANTILE ECZEMA, ASTHMA AND HAY FEVER IN MONGOLISM.

Authors:  M K COGHLAN; P R EVANS
Journal:  Guys Hosp Rep       Date:  1964

3.  Biochemical studies in mongolism. II: The influence of age and sex on the plasma proteins.

Authors:  M D APPLETON; G H PRITHAM
Journal:  Am J Ment Defic       Date:  1963-01

4.  Biochemical studies in mongolism. I: The influence of environment on the concentrations and mobilities of plasma proteins.

Authors:  G H PRITHAM; M D APPLETON; E R FLUCK
Journal:  Am J Ment Defic       Date:  1963-01

5.  Vitamin A absorption and other blood composition studies in mongolism.

Authors:  A E SOBEL; M STRAZZULLA; B S SHERMAN; B ELKAN; S W MORGENSTERN; N MARIUS; A MEISEL
Journal:  Am J Ment Defic       Date:  1958-01

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Serological properties of gamma-A antibodies to Escherichia coli present in human colostrum.

Authors:  M Adinolfi; A A Glynn; M Lindsay; C M Milne
Journal:  Immunology       Date:  1966-06       Impact factor: 7.397

8.  Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II).

Authors:  E M McKelvey; J L Fahey
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

  8 in total
  6 in total

1.  Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome.

Authors:  E McKay; G Hems; A Massie; M A Moffat; K M Phillips
Journal:  J Hyg (Lond)       Date:  1978-08

2.  On the influence of age on immunity in Down's syndrome.

Authors:  R Seger; G Buchinger; J Ströder
Journal:  Eur J Pediatr       Date:  1977-01-26       Impact factor: 3.183

3.  Gm antigenic titres in adults with Down's syndrome (mongolism), non-mongoloid mental defectives and healthy blood donors.

Authors:  H Thom; E McKay
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

4.  Serum globulins and infection in mongolism.

Authors:  A W Griffiths; P E Sylvester; E M Baylis
Journal:  J Clin Pathol       Date:  1969-01       Impact factor: 3.411

5.  Immunoglobulins and the X-chromosome.

Authors:  C B Wood; W Martin; M Adinolfi; P E Polani
Journal:  Br Med J       Date:  1969-10-11

6.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.